MARKET

PLSE

PLSE

Pulse Biosciences Inc
NASDAQ
16.84
+0.05
+0.30%
Pre Market: 16.22 -0.62 -3.68% 04:09 05/14 EDT
OPEN
16.75
PREV CLOSE
16.79
HIGH
17.03
LOW
16.32
VOLUME
1
TURNOVER
--
52 WEEK HIGH
25.00
52 WEEK LOW
6.66
MARKET CAP
1.13B
P/E (TTM)
-17.3769
1D
5D
1M
3M
1Y
5Y
1D
Pulse Biosciences Earnings Call: Progress and Challenges
TipRanks · 1d ago
Weekly Report: what happened at PLSE last week (0505-0509)?
Weekly Report · 2d ago
Pulse Biosciences GAAP EPS of -$0.25
Seeking Alpha · 5d ago
Pulse Biosciences Q1 EPS $(0.25) Down From $(0.15) YoY
Benzinga · 5d ago
Press Release: Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results
Dow Jones · 5d ago
Press Release: Pulse Biosciences Reports Business -2-
Dow Jones · 5d ago
*Pulse Biosciences 1Q Loss $16.8M >PLSE
Dow Jones · 5d ago
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference
Barchart · 05/06 15:05
More
About PLSE
More
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s CellFX Nanosecond Pulsed-Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. It is pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation (AF) and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation. Its nsPFA Percutaneous Electrode System consists of a disposable, percutaneous, needle electrode for use with its CellFX Console. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment of AF. The CellFX Console is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. It is also developing a Nanosecond PFA 360-degree Cardiac Catheter System.
Recently
Symbol
Price
%Change
    IWM
  • 208.63
  • +0.37%

Webull offers Pulse Biosciences Inc stock information, including NASDAQ: PLSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLSE stock methods without spending real money on the virtual paper trading platform.